Seattle, WA – May 15th, 2017 – Universal Cells announced today that a report from Universal Cells’ CSO Dr. David Russell and researchers at the University of Washington demonstrating the potential of Universal Cells’ technology for creating universal donor stem cells has been published in the journal Nature Biotechnology.
The paper’s focus is how normal human embryonic stem cells were engineered by nuclease-free rAAV-mediated gene editing to escape immune rejection by allogeneic T cells, B cells and NK cells.
“We are delighted to have Dr. Russell’s work showcased in Nature Biotechnology.” Universal Cells’ CEO, Dr. Claudia Mitchell said. “It attests to the importance and groundbreaking aspect of his research, which is the basis for Universal Cells’ technology.”
A link to the published article in Nature Biotechnology can be found here.